Sacro Cuore Hospital, Department of Ophthalmology, Negrar (Verona), Italy.
Department Computer Science, University of Verona, Verona, Italy.
Retina. 2019 Feb;39(2):288-295. doi: 10.1097/IAE.0000000000001945.
To investigate the long-term outcome of autologous retinal pigment epithelium -choroid transplantation with a peripheral retinotomy for exudative age-related macular degeneration.
In a retrospective study, we selected all patients who underwent a retinal pigment epithelium-choroid transplantation from 2007 through 2013. Exclusion criteria were age <60 years, <12 months of follow-up, and retinal pigment epithelium-choroid graft for other diseases than age-related macular degeneration. The main outcome measure was best-corrected visual acuity converted into logarithm of the minimum angle of resolution.
In this study, 81 patients were included with a mean follow-up of 38 months (SD = 19). Median best-corrected visual acuity improved from 1.30 logarithm of the minimum angle of resolution (20/400 Snellen) to 0.90 logarithm of the minimum angle of resolution (20/160 Snellen) 1 year after surgery (P < 0.001). A ≥3-line gain was achieved in 43 patients (53%) 1 year postoperatively and 37 patients (46%) preserved their visual gain until last visit. Of 4 patients with an 8-year follow-up, 3 patients had a ≥6-line gain at last visit. Severe complications were submacular hemorrhage (n = 8, 10%), macular hole (n = 6, 7%), and proliferative vitreoretinopathy (n = 3, 4%).
Best-corrected visual acuity improved significantly after retinal pigment epithelium-choroid transplantation in patients with age-related macular degeneration and preservation of visual gain was possible in the long term.
研究经周边视网膜切开术行自体视网膜色素上皮 -脉络膜移植治疗渗出性年龄相关性黄斑变性的长期疗效。
在一项回顾性研究中,我们选择了 2007 年至 2013 年间所有接受视网膜色素上皮 -脉络膜移植的患者。排除标准为年龄 <60 岁、随访时间 <12 个月以及因年龄相关性黄斑变性以外的疾病而行视网膜色素上皮 -脉络膜移植。主要观察指标为最佳矫正视力,换算为最小分辨角对数。
本研究共纳入 81 例患者,平均随访 38 个月(标准差 = 19)。术后 1 年,中位最佳矫正视力从 1.30 最小分辨角对数(20/400 Snellen)提高至 0.90 最小分辨角对数(20/160 Snellen)(P < 0.001)。术后 1 年,43 例(53%)患者视力提高 ≥3 行,37 例(46%)患者视力保持稳定。4 例患者随访 8 年,末次随访时 3 例患者视力提高 ≥6 行。严重并发症包括黄斑下出血(n = 8,10%)、黄斑裂孔(n = 6,7%)和增生性玻璃体视网膜病变(n = 3,4%)。
年龄相关性黄斑变性患者行视网膜色素上皮 -脉络膜移植后最佳矫正视力显著提高,且长期视力保持稳定。